PBH Prestige Consumer Healthcare Inc
215
$65.72
$1.02
(1.58%)
| Watchers | 215 |
| 52-Wk Low | $55.96 |
| 52-Wk High | $75.31 |
| Market Cap | $3.23B |
| Volume | 119,696.00 |
| 52-Wk High | $75.31 |
| 52-Wk Low | $55.96 |
Prestige Consumer Q4 Earnings Miss, Operating Margin FallsBenzinga • 5 days ago
Prestige Consumer Healthcare Inc. (NYSE: PBH) delivered fourth-quarter fiscal 2024 earnings per share of $1.02, a 4.7% decline from the year-ago period's figure. The metric also missed the Zacks...
Share to Feed
read more...
Vanguard Group Inc. trimmed its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH Free Report) by 0.7% in the 3rd quarter, according to the company in its most recent filing with the...
Nordea Investment Management AB cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH Free Report) by 2.8% during the fourth quarter, according to its most recent disclosure with the...
In recent trading, shares of Prestige Consumer Healthcare Inc (PBH) have crossed above the average analyst 12-month target price of 73.00, changing hands for 73.70/share. When a stock...
Prestige Consumer Healthcare Inc. (NYSE:PBH Get Free Report) reached a new 52-week high during trading on Thursday . The company traded as high as $72.17 and last traded at $71.95, with a...
This is a Bullish indicator signaling PBH's price could rise from here. Traders may explore going long the stock or buying call options...
Prestige Consumer Healthcare Inc. (NYSE:PBH Free Report) Equities researchers at Zacks Research upped their FY2024 earnings per share (EPS) estimates for shares of Prestige Consumer...
Mutual of America Capital Management LLC reduced its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH Free Report) by 10.6% during the 3rd quarter, according to its most recent Form 13F...
Nordea Investment Management AB lessened its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH Free Report) by 5.1% in the third quarter, according to its most recent...